Ignite Creation Date:
2024-05-05 @ 11:25 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00034372
Status:
TERMINATED
Last Update Posted:
2007-12-18
First Post:
2002-04-26
Brief Title:
Multicenter Clinical Trial of Intravenous OvaRex MAb-B4313 as Post-Chemotherapy Consolidation for Ovarian Carcinoma
Sponsor:
Unither Pharmaceuticals
Organization:
Unither Pharmaceuticals
Organization Data
Organization:
Unither Pharmaceuticals
Class:
INDUSTRY
Study ID:
OVA-Gy-15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Unither Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None